Academic Journal
Phytochemicals as Natural Therapeutics Against Helicobacter pylori: A Comprehensive Review.
| Τίτλος: | Phytochemicals as Natural Therapeutics Against Helicobacter pylori: A Comprehensive Review. |
|---|---|
| Συγγραφείς: | Shah SAR; Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Lahore, Pakistan. ali.raza@imbb.uol.edu.pk., Jamil H; Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Lahore, Pakistan., Mustafa I; Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Lahore, Pakistan., Sharif S; Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Lahore, Pakistan., Zahid Z; Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Lahore, Pakistan., Yasir A; Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Lahore, Pakistan., Nayila I; Department of Pharmacy, The University of Lahore, Sargodha Campus, Sargodha, Pakistan. |
| Πηγή: | Current microbiology [Curr Microbiol] 2026 Jul 23; Vol. 83 (9). Date of Electronic Publication: 2026 Jul 23. |
| Τύπος έκδοσης: | Journal Article; Review |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: Springer International Country of Publication: United States NLM ID: 7808448 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0991 (Electronic) Linking ISSN: 03438651 NLM ISO Abbreviation: Curr Microbiol Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: New York, Springer International. |
| Ιατρικοί όροι (MeSH): | Helicobacter pylori*/drug effects , Helicobacter pylori*/physiology , Phytochemicals*/pharmacology , Phytochemicals*/therapeutic use , Phytochemicals*/chemistry , Helicobacter Infections*/drug therapy , Helicobacter Infections*/microbiology , Anti-Bacterial Agents*/pharmacology , Anti-Bacterial Agents*/therapeutic use , Anti-Bacterial Agents*/chemistry, Biofilms/drug effects ; Plants, Medicinal/chemistry ; Humans ; Drug Resistance, Bacterial |
| Περίληψη: | Helicobacter pylori is considered as a high-priority pathogen by World Health Organization which causes chronic gastritis and peptic ulcer disease and gastric carcinoma. The organism uses several methods to establish its disease-causing ability through urease production CagA protein synthesis biofilm development and ongoing gastric tissue damage. The rising rates of antibiotic resistance have decreased the success rate of standard treatment methods that use proton pump inhibitors and other eradication protocols. The plant-based compounds provide immunomodulatory properties together with gastro-protective benefits which will help improve treatment results while reducing the risks that come with antibiotic resistance. Phytochemicals from medicinal plants have developed into effective natural treatments against H. pylori because they contain various mechanisms to combat the bacteria. To achieve a review study, academic databases such as PubMed, Web of Science, Scopus, and Google Scholar were searched to cover all the available literature. The anti-H. pylori activity of compounds from Curcuma longa, Zingiber officinale, Allium sativum, and Camellia sinensis stems from their ability to block bacterial attachment while they impede biofilm development and decrease the production of pathogenic factors and their effects on host immune systems. The overview presents scientific evidence which shows that phytochemicals have therapeutic value because they serve as natural treatments that help fight antibiotic resistance while improving H. pylori treatment methods. (© 2026. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.) |
| Competing Interests: | Declarations. Competing interests: The authors declare no competing interests. Consent to Participate: All authors are equally participated in prepration of this article. Consent for Publication: All authors are agree and have full support for publication of this study. Ethical Approval: Not required. AI Declaration: The authors declared that they use AI and Chat GPT for the improvement of illustrations, English language and grammar used in this manuscript. |
| References: | Pharmaceutics. 2022 Jan 14;14(1):. (PMID: 35057085) Molecules. 2022 Oct 25;27(21):. (PMID: 36364048) BMC Complement Med Ther. 2024 Feb 16;24(1):93. (PMID: 38365729) Antioxidants (Basel). 2022 Nov 23;11(12):. (PMID: 36552526) Front Microbiol. 2024 Jun 07;15:1418129. (PMID: 38912349) Environ Res. 2024 Feb 1;242:117763. (PMID: 38029828) Molecules. 2025 Jun 03;30(11):. (PMID: 40509336) Planta Med. 2020 Mar;86(4):224-238. (PMID: 31975363) Am J Clin Nutr. 2023 Jan;117(1):22-32. (PMID: 36789941) Front Immunol. 2023 Mar 09;14:1127704. (PMID: 36969193) Molecules. 2023 Feb 24;28(5):. (PMID: 36903396) Pharmaceuticals (Basel). 2024 Nov 19;17(11):. (PMID: 39598460) Molecules. 2023 Mar 07;28(6):. (PMID: 36985419) Molecules. 2023 Feb 01;28(3):. (PMID: 36771040) Foods. 2022 Sep 06;11(18):. (PMID: 36140867) Vet Med Sci. 2021 Sep;7(5):1959-1969. (PMID: 34191404) Nutrients. 2022 Apr 22;14(9):. (PMID: 35565724) Front Cell Infect Microbiol. 2021 Jul 20;11:709749. (PMID: 34354964) Int J Mol Sci. 2022 Apr 08;23(8):. (PMID: 35456938) Cell Signal. 2024 Dec;124:111465. (PMID: 39395527) J Ginseng Res. 2021 Jan;45(1):32-40. (PMID: 33437154) Nutrients. 2022 May 18;14(10):. (PMID: 35631245) Molecules. 2022 Jan 22;27(3):. (PMID: 35163989) Lab Anim Res. 2020 Oct 28;36:40. (PMID: 33134159) Phytother Res. 2020 Apr;34(4):685-720. (PMID: 31908068) Molecules. 2025 Feb 01;30(3):. (PMID: 39942757) J Ethnopharmacol. 2024 Nov 15;334:118594. (PMID: 39032662) Plants (Basel). 2023 Aug 28;12(17):. (PMID: 37687324) Gastroenterol Res Pract. 2020 Jan 28;2020:9342563. (PMID: 32411209) Nutrients. 2024 Aug 24;16(17):. (PMID: 39275155) Curr Pharm Des. 2020;26(8):815-837. (PMID: 32091328) Front Pharmacol. 2021 Sep 06;12:723233. (PMID: 34552489) Antibiotics (Basel). 2024 Aug 09;13(8):. (PMID: 39200046) Adv Biomed Res. 2025 Feb 28;14:10. (PMID: 40213600) Molecules. 2020 Sep 09;25(18):. (PMID: 32917001) Pharmaceuticals (Basel). 2022 Oct 19;15(10):. (PMID: 36297396) Metabolites. 2024 Apr 07;14(4):. (PMID: 38668338) Biotechnol Appl Biochem. 2022 Dec;69(6):2357-2386. (PMID: 34826356) Nutrients. 2024 Dec 17;16(24):. (PMID: 39770978) Int J Mol Sci. 2023 May 10;24(10):. (PMID: 37239888) Mol Med. 2023 Apr 10;29(1):51. (PMID: 37038107) Int J Mol Sci. 2022 Dec 21;24(1):. (PMID: 36613542) Crit Rev Microbiol. 2022 May;48(3):376-396. (PMID: 34569892) Int J Mol Sci. 2022 Jul 08;23(14):. (PMID: 35886908) J Trop Pediatr. 2021 Jan 29;67(1):. (PMID: 33099650) ACS Omega. 2023 May 02;8(19):16600-16611. (PMID: 37214690) Molecules. 2023 Oct 07;28(19):. (PMID: 37836809) J Am Nutr Assoc. 2022 Jan;41(1):65-93. (PMID: 33216711) Front Pharmacol. 2021 Jan 08;11:586548. (PMID: 33488385) Molecules. 2022 Apr 30;27(9):. (PMID: 35566230) Metabolites. 2023 Jan 16;13(1):. (PMID: 36677061) Gut. 2022 Aug 11;71(9):1724-1762. (PMID: 35944925) Adv Pharm Bull. 2022 Aug;12(4):712-729. (PMID: 36415638) Front Immunol. 2020 Sep 25;11:2192. (PMID: 33072084) Microorganisms. 2020 Aug 31;8(9):. (PMID: 32878302) Pathogens. 2023 Feb 15;12(2):. (PMID: 36839605) Molecules. 2020 Jun 24;25(12):. (PMID: 32599926) Antibiotics (Basel). 2024 Oct 09;13(10):. (PMID: 39452214) Sci Rep. 2025 Mar 12;15(1):8481. (PMID: 40074793) Elife. 2021 Feb 03;10:. (PMID: 33533717) Int J Mol Sci. 2020 Sep 24;21(19):. (PMID: 32987946) Cancers (Basel). 2020 Mar 27;12(4):. (PMID: 32230726) |
| Substance Nomenclature: | 0 (Phytochemicals) 0 (Anti-Bacterial Agents) |
| Entry Date(s): | Date Created: 20260723 Date Completed: 20260723 Latest Revision: 20261008 |
| Update Code: | 20261008 |
| DOI: | 10.1007/s00284-026-05078-8 |
| PMID: | 42493637 |
| Βάση Δεδομένων: | MEDLINE |
καταχωρήστε σχόλιο πρώτοι!